Health Catalyst Inc (HCAT)
8.31
-0.08
(-0.95%)
USD |
NASDAQ |
Sep 27, 16:00
8.34
+0.03
(+0.36%)
After-Hours: 20:00
Health Catalyst Research and Development Expense (Annual): 72.63M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 72.63M |
| December 31, 2022 | 75.68M |
| December 31, 2021 | 62.73M |
| December 31, 2020 | 53.52M |
| Date | Value |
|---|---|
| December 31, 2019 | 46.25M |
| December 31, 2018 | 38.59M |
| December 31, 2017 | 28.47M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
46.25M
Minimum
2019
75.68M
Maximum
2022
62.16M
Average
62.73M
Median
2021